Federal ALS expanded-access research funding opportunity
NIH posted a 2026 funding opportunity for ALS intermediate-size patient-population expanded-access research, with applications due November 10, 2026.
Federal · Active · Implementation Nov 10, 2026
What it is
- What changed
- NIH/NINDS issued RFA-NS-26-001 to support scientific research using data from expanded access for investigational ALS drugs or biological products in intermediate-size patient populations.
- Why it matters
- Expanded-access research can affect treatment-access pathways and planning conversations for ALS families who are not eligible for ongoing clinical trials, while remaining distinct from benefits eligibility or guaranteed treatment access.
- Who it touches
- Family caregivers, Care providers and plans, People receiving carepeople living with ALS, ALS caregivers, clinical trial sites, research sponsors
- What it does
- Funds programs or services; Plans, studies, registries or guidance
Sources
Last reviewed Jul 4, 2026. This is information, not legal advice; check the source for the current text.